Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GMRS · against 483 other Healthcare companies of similar size
Ranked #88 of 484 · scores higher than 82% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 80–89, including GMRS · Click a bar to see the companies
Mainly thanks to its EBITDA yield, which is stronger than most Healthcare peers.
| Metric | GMRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 471 reported | -17.8% | 0.8% | 13% | 30% | |
| EBITDA yieldHigher is better · 488 reported | 20.2% | 3.7% | 94% | 50% | |
| Free cash flow yieldHigher is better · 205 reported | Not reported | -4.3% | — | — | 20% |
| Book yieldHigher is better · 483 reported | 89.2% | 45.6% | 80% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score